Generics 1

Originals

Biosimilars 1

Medical devices

Nutraceuticals

Filters

Insulin aspart manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

1 products found

insulin degludec + insulin aspart

Injection 300 IU - 3 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #38346
Manufacturer was incorporated on 27 December 2021 in Surat, Gujarat, India, with about 28 employees. As a CTD dossier owner and manufacturer, it operates a WHO-GMP certified and EU-compliant formulation plant under CGMP norms. Products reach markets in India, Yemen, Zambia, Venezuela, Ghana, Kenya, and Tanzania for international presence. Designed to comply with rigorous “Revised Schedule M” rules from India’s Drug Controller. As a CTD dossier owner and manufacturer, it aims for regulatory readiness in global submissions. Recognized as a GMP manufacturer, it ensures standards of safety, purity, and efficacy in all batches.

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible